secwatch.observer — SEC 8-K summary
======================================

Issuer:     RF Acquisition Corp II (RFAI)
CIK:        0002012807
Form:       8-K
Filed at:   2026-08-20T20:49:43+00:00
Accession:  0001829126-26-009168
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RF Acquisition Corp II shareholders approve Nanyang Biologics deal; 3.96M shares seek redemption
--------------------------------------------------------------------------------

- All six proposals approved at Aug 19 EGM: 6,765,584 for, 440,604 against, 0 abstain.
- Preliminary redemption requests for 3,956,323 ordinary shares from trust account (~47.4% of outstanding).
- Business combination with Nanyang Biologics Pte. Ltd. via NYB Holdings remains subject to closing conditions.
- Quorum of 7,206,188 shares (86.36%) present; record date May 20, 2026.
- Redemption requests may be withdrawn with consent; final per-share price and trust proceeds pending closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2012807/000182912626009168/0001829126-26-009168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2012807/000182912626009168/rfacquisition2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-009168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer